Article

Glycemic instability in type 1 diabetic patients: Possible role of ketosis or ketoacidosis at onset of diabetes.

Department of Diabetes and Clinical Nutrition, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Diabetes research and clinical practice (impact factor: 2.16). 06/2008; 81(2):190-5. DOI:10.1016/j.diabres.2008.04.009 pp.190-5
Source: PubMed

ABSTRACT In type 1 diabetic patients, some have glycemic instability while others glycemic stability. We have developed criteria for evaluating glycemic instability and investigated the factors responsible.
Glycemic instability in 52 type 1 diabetic patients was assessed by the mean amplitude of glycemic excursions (MAGE) and M-value, and clinical characteristics of good, fair and poor control groups were compared.
The median MAGE and M-value was 6.6mmol/L and 18.7, respectively. Then MAGE >or=6.6mmol/L and M-value >or=18.7 was defined as poor control. In the 32 patients without detectable C-peptide levels, 18 patients (56%) showed poor control. The frequency of ketosis or ketoacidosis at onset of diabetes was dramatically higher in the poor control group not only in the patients as a whole but also in those without detectable C-peptide levels.
A decreased level of C-peptide is a significant factor in glycemic instability. However, some patients have glycemic stability though beta-cell function is completely depleted. The presence of ketosis or ketoacidosis at onset of diabetes may be a factor in later glycemic instability, suggesting the importance of examining patients in detail at onset of diabetes for careful follow-up to prevent progression of acute and chronic complications of diabetes.

0 0
 · 
0 Bookmarks
 · 
37 Views

Keywords

18 patients
 
52 type 1 diabetic patients
 
beta-cell function
 
C-peptide
 
careful follow-up
 
chronic complications
 
clinical characteristics
 
decreased level
 
detectable C-peptide levels
 
factors responsible
 
glycemic excursions
 
Glycemic instability
 
ketosis
 
mean amplitude
 
others glycemic stability
 
poor control
 
poor control group
 
poor control groups
 
significant factor
 
type 1 diabetic patients